Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update

被引:0
作者
Ali Tootee
Bagher Larijan
机构
[1] Tehran University of Medical Sciences,Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[2] Tehran University of Medical Sciences,Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute
来源
Journal of Diabetes & Metabolic Disorders | 2021年 / 20卷
关键词
Ramadan Fasting; Fasting; Diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
Development of updated guidelines for management of diabetes in Ramadan Fasting is of paramount importance. Nonetheless, evidence-based guidelines in the field of Ramadan Fasting and Diabetes are scarce. Moreover, findings of some recent research such as effects of Ramadan fasting on microbiota, genetics and epigenetics, hormonal changes (such as adiponectin, leptin, testosterone…), and alternations in circadian rhythm should also be reviewed and included on a yearly basis. It is documented that self-monitoring of blood glucose (SMBG) is of vital importance for patients with type 1 diabetes who fast, and advantages of continuous glucose monitoring (CGM) or flash glucose monitoring (FGM) techniques should be highlighted. Moreover, the recent findings about applications of advanced insulin delivery technology in patients with diabetes who fast in Ramadan should also considered in the annual updates of the guidelines.
引用
收藏
页码:1085 / 1091
页数:6
相关论文
共 272 条
[21]  
AlRasheed AN(2017)Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes Diabetes Res Clin Pract 126 303-129
[22]  
AlBattal SM(2017)effects of Ramadan fasting on children with type 1 diabetes J Endocrinol Invest 40 741-15
[23]  
Abdelhay O(2010)Insulin dosing for fat and protein: is it time? International Journal of Diabetes Mellitus 2 127-60
[24]  
Benaji B(2020)Fasting during the month of Ramadan for people with diabetes: medicine and Fiqh united at last Diabetes Care 43 13-26
[25]  
Mounib N(2009)CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents Ibnosina J Med Biomed Sci 1 58-314
[26]  
Roky R(2017)Incidence of hypoglycaemia in patients with type-2 diabetes taking multiple glucose lowering therapies during Ramadan: the PROFAST Ramadan Study Diabetes Res Clin Pract 132 19-76
[27]  
Aadil N(2018)A double-blind, randomized, multicenter study evaluating the effects of pioglitazone in fasting Muslim subjects during Ramadan J Diabetes Metab Disord 17 309-147
[28]  
Houti I(2006)A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting Int J Diabetes Dev Ctries 26 70-35
[29]  
Moussamih S(2007)An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan Diabetes Res Clin Pract 75 141-53
[30]  
Bravis V(2006)Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting Med J Malaysia 61 28-206